These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection. Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078 [TBL] [Abstract][Full Text] [Related]
10. Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis. Porter LA; Goldberg JB Front Cell Infect Microbiol; 2011; 1():9. PubMed ID: 22919575 [TBL] [Abstract][Full Text] [Related]
11. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. Horsley A; Jones AM Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960 [TBL] [Abstract][Full Text] [Related]
12. Accurate identification of members of the Burkholderia cepacia complex in cystic fibrosis sputum. Martinucci M; Roscetto E; Iula VD; Votsi A; Catania MR; De Gregorio E Lett Appl Microbiol; 2016 Mar; 62(3):221-9. PubMed ID: 26671758 [TBL] [Abstract][Full Text] [Related]
13. Novel antibiotic combinations proposed for treatment of El-Halfawy OM; Naguib MM; Valvano MA Antimicrob Resist Infect Control; 2017; 6():120. PubMed ID: 29204272 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous coinfection by multiple strains during Burkholderia cepacia complex infection in cystic fibrosis. Yang JH; Spilker T; LiPuma JJ Diagn Microbiol Infect Dis; 2006 Feb; 54(2):95-8. PubMed ID: 16406186 [TBL] [Abstract][Full Text] [Related]
15. Molecular typing of Burkholderia cepacia complex isolated from patients attending an Italian Cystic Fibrosis Centre. Teri A; Sottotetti S; Biffi A; Girelli D; D'Accico M; Arghittu M; Colombo C; Corti F; Pizzamiglio G; Cariani L New Microbiol; 2018 Apr; 41(2):141-144. PubMed ID: 29498745 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Bacterial Growth by Peptide-Conjugated Morpholino Oligomers. Daly SM; Sturge CR; Greenberg DE Methods Mol Biol; 2017; 1565():115-122. PubMed ID: 28364238 [TBL] [Abstract][Full Text] [Related]
17. Direct culture-independent Strain typing of Burkholderia cepacia complex in sputum samples from patients with cystic fibrosis. Drevinek P; Vosahlikova S; Dedeckova K; Cinek O; Mahenthiralingam E J Clin Microbiol; 2010 May; 48(5):1888-91. PubMed ID: 20181898 [TBL] [Abstract][Full Text] [Related]
18. Sequence specificity defines the effectiveness of PPMOs targeting Nanayakkara AK; Moustafa DA; Pifer R; Goldberg JB; Greenberg DE Antimicrob Agents Chemother; 2023 Sep; 67(9):e0024523. PubMed ID: 37610213 [TBL] [Abstract][Full Text] [Related]
19. The antibacterial properties of docosahexaenoic omega-3 fatty acid against the cystic fibrosis multiresistant pathogen Burkholderia cenocepacia. Mil-Homens D; Bernardes N; Fialho AM FEMS Microbiol Lett; 2012 Mar; 328(1):61-9. PubMed ID: 22150831 [TBL] [Abstract][Full Text] [Related]